2019

CellaVision's Annual General Meeting in 2019 will take place in Lund at three o´clock CET on May 8, 2019.

The superior body of the company is the Annual General Meeting, where the shareholders influence in the company is exercised. At the Annual General Meeting decisions are made on a number of central items of business, including the appropriation of the company’s profits, adoption of the income statement and balance sheet, discharge from liability of the Board of Directors and President/CEO, election of the Board of Directors and auditor and fees to the Board of Directors and auditor.

Shareholders wishing to have matters considered at the Annual General Meeting can send a written request by email to bolagsstamma@cellavision.se or ordinary mail to: The Board of Directors, CellaVision AB, Mobilvägen 12, SE 223 62 Lund. The request must have been received at the latest seven weeks before the Annual General Meeting in order to be included in the notice to attend and thus the agenda of the Annual General Meeting.

To be entitled to participate and vote their shares at the Annual General Meeting, shareholders must be entered in the share register and give notice of attendance within a certain time limit. Shareholders unable to participate in person can do so via a proxy. Information about the registration can be found in the Notice to the Annual General Meeting.

Documents for download (pdf)
Notice (SWE)
Proxy (SWE)
The Nomination Committee's Motivated Statement (SWE)
The Nomination Committee's supplements its proposal with additional Board member
Presentation of proposed board members (SWE)
Proposed guidelines for remuneration to senior management in 2016 (SWE)
CellaVision Annual Report 2017
Auditor's opinion (SWE)
Report by the Board of Directors, on the remuneration committee's evaluation of compensation to senior management (SWE)
Bullletin from CellaVision's AGM 2016 (EN)
CEO presentation (EN)
Minutes (SWE)
Appendix 3 (SWE)
Appendix 4 (SWE)

2018

CellaVision's Annual General Meeting in 2018 will take place in Lund at three o´clock CET on May 4, 2018.

The superior body of the company is the Annual General Meeting, where the shareholders influence in the company is exercised. At the Annual General Meeting decisions are made on a number of central items of business, including the appropriation of the company’s profits, adoption of the income statement and balance sheet, discharge from liability of the Board of Directors and President/CEO, election of the Board of Directors and auditor and fees to the Board of Directors and auditor.

Shareholders wishing to have matters considered at the Annual General Meeting can send a written request by email to bolagsstamma@cellavision.se or ordinary mail to: The Board of Directors, CellaVision AB, Mobilvägen 12, SE 223 62 Lund. The request must have been received at the latest seven weeks before the Annual General Meeting in order to be included in the notice to attend and thus the agenda of the Annual General Meeting.

To be entitled to participate and vote their shares at the Annual General Meeting, shareholders must be entered in the share register and give notice of attendance within a certain time limit. Shareholders unable to participate in person can do so via a proxy. Information about the registration can be found in the Notice to the Annual General Meeting.

Documents for download (pdf)
Notice (SWE)
Proxy (SWE)
The Nomination Committee's Motivated Statement (SWE)
The Nomination Committee's supplements its proposal with additional Board member
Presentation of proposed board members (SWE)
Proposed guidelines for remuneration to senior management in 2016 (SWE)
CellaVision Annual Report 2017
Auditor's opinion (SWE)
Report by the Board of Directors, on the remuneration committee's evaluation of compensation to senior management (SWE)
Bullletin from CellaVision's AGM 2016 (EN)
CEO presentation (EN)
Minutes (SWE)
Appendix 3 (SWE)
Appendix 4 (SWE)

 

2017

CellaVision's Annual General Meeting in 2017 will take place in Lund at three o´clock CET on May 5, 2017.

The superior body of the company is the Annual General Meeting, where the shareholders influence in the company is exercised. At the Annual General Meeting decisions are made on a number of central items of business, including the appropriation of the company’s profits, adoption of the income statement and balance sheet, discharge from liability of the Board of Directors and President/CEO, election of the Board of Directors and auditor and fees to the Board of Directors and auditor.

Shareholders wishing to have matters considered at the Annual General Meeting can send a written request by email to bolagsstamma@cellavision.se or ordinary mail to: The Board of Directors, CellaVision AB, Ideon Science Park, SE 223 70 Lund. The request must have been received at the latest seven weeks before the Annual General Meeting in order to be included in the notice to attend and thus the agenda of the Annual General Meeting.

To be entitled to participate and vote their shares at the Annual General Meeting, shareholders must be entered in the share register and give notice of attendance within a certain time limit. Shareholders unable to participate in person can do so via a proxy. Information about the registration can be found in the Notice to the Annual General Meeting.

Documents for download (pdf)
Notice (SWE)
Proxy (SWE)
The Nomination Committee's Motivated Statement (SWE)
Presentation of proposed board members (SWE)
Proposed guidelines for remuneration to senior management in 2016 (SWE)
Auditor's opinion (SWE)
Report by the Board of Directors, on the remuneration committee's evaluation of compensation to senior management (SWE)
Bullletin from CellaVision's AGM 2016 (EN)
CEO presentation (EN)
Minutes (SWE)
Appendix 3 and 4

 

2016

CellaVision's Annual General Meeting in 2016 was held in Lund at three o´clock CET on May 4, 2016.

The superior body of the company is the Annual General Meeting, where the shareholders influence in the company is exercised. At the Annual General Meeting decisions are made on a number of central items of business, including the appropriation of the company’s profits, adoption of the income statement and balance sheet, discharge from liability of the Board of Directors and President/CEO, election of the Board of Directors and auditor and fees to the Board of Directors and auditor.

Shareholders wishing to have matters considered at the Annual General Meeting can send a written request by email to bolagsstamma@cellavision.se or ordinary mail to: The Board of Directors, CellaVision AB, Ideon Science Park, SE 223 70 Lund. The request must have been received at the latest seven weeks before the Annual General Meeting in order to be included in the notice to attend and thus the agenda of the Annual General Meeting.

To be entitled to participate and vote their shares at the Annual General Meeting, shareholders must be entered in the share register and give notice of attendance within a certain time limit. Shareholders unable to participate in person can do so via a proxy. Information about the registration can be found in the Notice to the Annual General Meeting.

Documents for download (pdf)
Notice (SWE)
Proxy (SWE)
The Nomination Committee's Motivated Statement (SWE)
Presentation of proposed board members (SWE)
Proposed guidelines for remuneration to senior management in 2016 (SWE)
Auditor's opinion (SWE)
Report by the Board of Directors, on the remuneration committee's evaluation of compensation to senior management (SWE)
Bullletin from CellaVision's AGM 2016 (EN)
CEO presentation (SWE)
Minutes (SWE)

 

2015

CellaVision's Annual General Meeting in 2015 will be held in Lund on May 6, 2015.

The superior body of the company is the Annual General Meeting, where the shareholders influence in the company is exercised. At the Annual General Meeting decisions are made on a number of central items of business, including the appropriation of the company’s profits, adoption of the income statement and balance sheet, discharge from liability of the Board of Directors and President/CEO, election of the Board of Directors and auditor and fees to the Board of Directors and auditor.

Shareholders wishing to have matters considered at the Annual General Meeting can send a written request by email to bolagsstamma@cellavision.se or ordinary mail to: The Board of Directors, CellaVision AB, Ideon Science Park, SE 223 70 Lund.

The request must have been received at the latest seven weeks before the Annual General Meeting in order to be included in the notice to attend and thus the agenda of the Annual General Meeting.

To be entitled to participate and vote their shares at the Annual General Meeting, shareholders must be entered in the share register and give notice of attendance within a certain time limit. Shareholders unable to participate in person can do so via a proxy. Information about the registration can be found in the Notice to the Annual General Meeting.

Documents for download (pdf)

Notice (SWE)
Proxy (SWE)
The Nomination Committee's Motivated Statement (SWE)
Presentation of proposed board members (SWE)
Proposed guidelines for remuneration to senior management in 2015 (SWE)
Auditor's opinion (SWE)
Report by the Board of Directors, on the remuneration committee's evaluation of compensation to senior management (SWE)
Bullletin from CellaVision's AGM 2015 (EN)
CEO presentation (SWE)
Minutes (SWE)

2014

CellaVision's Annual General Meeting in 2014 will be held in Lund on May 7, 2014.

The superior body of the company is the Annual General Meeting, where the shareholders influence in the company is exercised. At the Annual General Meeting decisions are made on a number of central items of business, including the appropriation of the company’s profits, adoption of the income statement and balance sheet, discharge from liability of the Board of Directors and President/CEO, election of the Board of Directors and auditor and fees to the Board of Directors and auditor.

To be entitled to participate and vote their shares at the Annual General Meeting, shareholders must be entered in the share register and give notice of attendance within a certain time limit. Shareholders unable to participate in person can do so via a proxy. Information about the registration can be found in the Notice to the Annual General Meeting.

Documents for download (pdf)

Notice (SWE)
Proxy (SWE)
The Nomination Committee's Motivated Statement (SWE)
Presentation of proposed board members (EN)
Proposed guidelines for remuneration to senior management in 2014 (SWE)
Auditor's opinion (SWE)
Report by the Board of Directors, on the remuneration committee's evaluation of compensation to senior management (SWE)
Bullletin from CellaVision's AGM 2014 (EN)
CEO presentation (EN)
Minutes (SWE)

2012

The Annual General Meeting 2012 was held on May 2, 2012 in Lund, Sweden.

The superior body of the company is the Annual General Meeting, where the shareholders influence in the company is exercised. At the Annual General Meeting decisions are made on a number of central items of business, including the appropriation of the company’s profits, adoption of the income statement and balance sheet, discharge from liability of the Board of Directors and President/CEO, election of the Board of Directors and auditor and fees to the Board of Directors and auditor.

To be entitled to participate and vote their shares at the Annual General Meeting, shareholders must be entered in the share register and give notice of attendance within a certain time limit. Shareholders unable to participate in person can do so via a proxy. Information about the registration can be found in the Notice to the Annual General Meeting.

Matters to be dealt with at the meeting
A shareholder has the right to have a matter addressed at an Annual General Meeting. A condition is that the shareholder has notified the Board of Directors within a specified time. A request from a shareholder to have a matter dealt with at the 2012 Annual General Meeting should be received by the Board of Directors no later than seven weeks before the Meeting, in order for the company to include the issue in the notice. The request should be sent either by e-mail on the address ir@cellavision.com or by regular mail on the address:

The Board of Directors of CellaVision AB, Ideon Science Park, 223 70 Lund, Sweden

Documents for download (pdf)

Notice (SWE)
Proxy (SWE)
The Nomination Committee's Proposal (SWE)
The Nomination Committee's Motivated Statement (SWE)
Presentation of proposed board members (EN)
Documentation to be presented at the AGM (SWE)
Auditor's opinion (SWE)
Report by the Board of Directors, on the remuneration committee's evaluation of compensation to senior management (SWE)
Bullletin from CellaVision's AGM 2012 (EN)
CEO presentation (EN)
Minutes (SWE)

2011

The Annual General Meeting 2011 was held on Tuesday April 26, 2011 at 17.00 at CellaVision AB, Scheelevägen 19 A, Ideon, in Lund, Sweden.

The superior body of the company is the Annual General Meeting, where the shareholders influence in the company is exercised. Shareholders who are registered in the share register held by Euroclear Sweden AB as of the record day and are registered in the manner described in the Articles of Association has the right to participate at the Annual General Meeting, in person or by a representative. At the Annual General Meeting all shareholders have the same initiative, participation and voting rights. At the Annual General Meeting Members of the Board are elected and when applicable also auditors, the manner in which the nomination committee shall be elected and if the Board of Directors and the CEO shall be discharged from liability for the fiscal year. Decisions are also made concerning establishment of financial reports, allocation of earnings, fees for the Board of Directors and the auditors, guidelines for remuneration of the CEO and other Managers and other essential matters that requires decisions by the Meeting. Normally decisions require a simple majority but the Swedish Companies Act dictates other majority requirements in certain matters.

Documents for download (pdf)

Notice (SWE)
Proxy (SWE)
The Nomination Committee's Proposal (SWE)
The Nomination Committee's Motivated Statement (SWE)
Presentation of proposed board members (SWE)
Documentation to be presented at the AGM (SWE)
Auditor's opinion (SWE)
Report by the Board of Directors, on the remuneration committee's evaluation of compensation to senior management (SWE)
Bullletin from CellaVision's AGM 2011 (SWE)
CEO presentation (EN)
Minutes (SWE)

Access our Student Resources

To access this resource, please provide the following information about yourself.